|
Volumn 25, Issue 8 SUPPL., 2005, Pages
|
Screening existing drugs for neurodegeneration: The National Institute of Neurologic Disorders and Stroke (NINDS) model
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE;
CEFTRIAXONE;
CEPHALOSPORIN;
CREATINE;
GLUTAMIC ACID;
MINOCYCLINE;
NEUROPROTECTIVE AGENT;
TSUKUBAENOLIDE;
ALZHEIMER DISEASE;
AMYOTROPHIC LATERAL SCLEROSIS;
BLOOD BRAIN BARRIER;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG DETERMINATION;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG POTENCY;
DRUG SAFETY;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ORGANIZATION;
HUMAN;
HUNTINGTON CHOREA;
INFORMATION PROCESSING;
NERVE DEGENERATION;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
PARKINSON DISEASE;
STROKE;
ANIMAL;
BIOLOGICAL MODEL;
DRUG DESIGN;
METHODOLOGY;
REVIEW;
UNITED STATES;
ANIMALS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
MODELS, BIOLOGICAL;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NERVOUS SYSTEM DISEASES;
UNITED STATES;
|
EID: 33644877920
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: 10.1097/00006982-200512001-00025 Document Type: Conference Paper |
Times cited : (8)
|
References (0)
|